Vanguard Fiduciary Trust’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
Other funds holding LAB
LFCM
Vanguard Fiduciary Trust's LAB Position: Q3 2026 in Review
Vanguard Fiduciary Trust reduced its Standard BioTools (LAB) stake by 3.8% in Q3 2026, selling an estimated $55.2K and leaving 1,818,058 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2845.
Vanguard Fiduciary Trust first reported a position in LAB in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.76M in Q1 2026. 104 funds tracked by Wall St. Rank hold LAB as of Q3 2026.
- Vanguard Fiduciary Trust held 1,818,058 shares of Standard BioTools worth $1.35M as of Q3 2026.
- Vanguard Fiduciary Trust sold 71,788 Standard BioTools shares in Q3 2026, an estimated $55.2K.
- Standard BioTools made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q3 2026, its #2845 holding.
- Vanguard Fiduciary Trust first reported a position in Standard BioTools in Q1 2026 and has held it in 3 quarters since.
- Vanguard Fiduciary Trust's Standard BioTools position peaked at $1.76M in Q1 2026.
- 104 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2026.
Based on Vanguard Fiduciary Trust's 13F filing for Q3 2026, filed 13 Nov 2026.